B cell CLL/lymphoma 1 ; B cell leukemia 1 ; B-cell lymphoma 1 protein ; BCL-1 oncogene ; CCND1 protein ; CCND1/FSTL3 fusion gene ; CCND1/IGHG1 fusion gene CCND1/IGLC1 fusion gene ; CCND1/PTH fusion gene ; cD1 ; Cyl 1
Categories
Primary Antibodies
Cellular Localization
Nuclear
Chromosome Location
11q13.2
Clonality
Monoclonal
Description
Recognizes a protein of 36kDa, identified as cyclin D1. Cyclin D1, one of the key cell cycle regulators, is a putative proto-oncogene overexpressed in a wide variety of human neoplasms. This antibody neutralizes the activity of cyclin D1 in vivo. About 60% of mantle cell lymphomas (MCL) contain a t(11; 14)(q13; q32) translocation resulting in over-expression of cyclin D1. This antibody is useful in identifying mantle cell lymphomas (cyclin D1 positive) from CLL/SLL and follicular lymphomas (cyclin D1 negative). About 40% of breast carcinomas are positive for Cyclin D1. Occasionally, hairy cell leukemia and plasma cell myeloma weakly express Cyclin D1.
Host
Mouse
Immunogen
Human full length recombinant cyclin D1 protein
Isotype
IgG2a Kappa
Positive Control
T47D, ZR75, BT474, SKBR3, MCF-7, MDA-MB-453, HT29, Ramos, Jurkat or A431 cells. Mantle cell lymphoma, breast or bladder carcinomas.
Reactivity
Human, Monkey, Mouse, Rat
Recombinant
FALSE
Regulatory
RUO
Swissprot
P24385
Uniprot
523852; 667996
Gene Id
595
Buffer
200μg/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.
Concentration
1.0mg/ml
Description
There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.
Purity
Purified Ab WITHOUT BSA and Azide at 1.0mg/ml
Applications
FACS, IF, WB, IHC-F
Description
(Staining of formalin-fixed tissues requires boiling tissue sections in 10mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes); Optimal dilution for a specific application should be determined., FACS ; IF ; WB ; IHC-F